BRTX vs VMC · rev $401.0K vs P/E 35, rev $7.42B
BioRestorative Therapies Inc (BRTX) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
BRTX currently screens at market cap $10.2M. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the BRTX and VMC stock pages for the full models.
Not investment advice.